rs11568546
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000323346.10(SLC17A8):āc.336T>Cā(p.Asp112=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0031 in 1,614,114 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0026 ( 1 hom., cov: 31)
Exomes š: 0.0032 ( 11 hom. )
Consequence
SLC17A8
ENST00000323346.10 synonymous
ENST00000323346.10 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.596
Genes affected
SLC17A8 (HGNC:20151): (solute carrier family 17 member 8) This gene encodes a vesicular glutamate transporter. The encoded protein transports the neurotransmitter glutamate into synaptic vesicles before it is released into the synaptic cleft. Mutations in this gene are the cause of autosomal-dominant nonsyndromic type 25 deafness. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 12-100380935-T-C is Benign according to our data. Variant chr12-100380935-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 47883.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-100380935-T-C is described in Lovd as [Likely_benign]. Variant chr12-100380935-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.596 with no splicing effect.
BS2
High AC in GnomAd4 at 397 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC17A8 | NM_139319.3 | c.336T>C | p.Asp112= | synonymous_variant | 2/12 | ENST00000323346.10 | NP_647480.1 | |
SLC17A8 | NM_001145288.2 | c.336T>C | p.Asp112= | synonymous_variant | 2/11 | NP_001138760.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC17A8 | ENST00000323346.10 | c.336T>C | p.Asp112= | synonymous_variant | 2/12 | 1 | NM_139319.3 | ENSP00000316909 | P1 | |
SLC17A8 | ENST00000392989.3 | c.336T>C | p.Asp112= | synonymous_variant | 2/11 | 1 | ENSP00000376715 |
Frequencies
GnomAD3 genomes AF: 0.00262 AC: 398AN: 152152Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
398
AN:
152152
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00275 AC: 692AN: 251426Hom.: 1 AF XY: 0.00275 AC XY: 374AN XY: 135886
GnomAD3 exomes
AF:
AC:
692
AN:
251426
Hom.:
AF XY:
AC XY:
374
AN XY:
135886
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00315 AC: 4605AN: 1461844Hom.: 11 Cov.: 31 AF XY: 0.00310 AC XY: 2258AN XY: 727226
GnomAD4 exome
AF:
AC:
4605
AN:
1461844
Hom.:
Cov.:
31
AF XY:
AC XY:
2258
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00261 AC: 397AN: 152270Hom.: 1 Cov.: 31 AF XY: 0.00228 AC XY: 170AN XY: 74456
GnomAD4 genome
AF:
AC:
397
AN:
152270
Hom.:
Cov.:
31
AF XY:
AC XY:
170
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | SLC17A8: BP4, BP7 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2021 | - - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 03, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 07, 2012 | Asp112Asp in Exon 02 of SLC17A8: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 0.4% (28/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs11568546). - |
Autosomal dominant nonsyndromic hearing loss 25 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at